Wyeth To Add “Consult a Doctor” For Cough/Cold Use By Children 2 To 6
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare is re-labeling its OTC pediatric cough/cold medicines to advise caregivers to consult physicians before administering the products to 2- to 6-year-old children, the firm says in comments submitted to FDA Oct. 3
You may also be interested in...
Wyeth Replaces Dosing Measure For Pediatric Dimetapp, Robitussin Products
Wyeth Consumer Healthcare is voluntarily recalling and replacing Children's Dimetapp Cold & Chest Congestion and multiple products in its Robitussin line because the products' dosing cups are not marked with half-teaspoon units, the recommended dose for children ages 2 to 6, the firm said Oct. 29
Wyeth Replaces Dosing Measure For Pediatric Dimetapp, Robitussin Products
Wyeth Consumer Healthcare is voluntarily recalling and replacing Children's Dimetapp Cold & Chest Congestion and multiple products in its Robitussin line because the products' dosing cups are not marked with half-teaspoon units, the recommended dose for children ages 2 to 6, the firm said Oct. 29
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
Manufacturers of OTC cough/cold medicines for children under 2 years old are voluntarily withdrawing the products from the market due to potential misuse, not from product safety concerns, the Consumer Healthcare Products Association said Oct. 11